T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors
Author:
Affiliation:
1. Department of Cancer Immunology; Oslo University Hospital; The Norwegian Radium Hospital; Montebello Oslo Norway
Funder
Kreftforeningen
Publisher
Wiley
Subject
Immunology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/sji.12643/fullpdf
Reference74 articles.
1. Cancer antigens: immune recognition of self and altered self;Houghton;J Exp Med,1994
2. Human neoplasms elicit multiple specific immune responses in the autologous host;Sahlin;Proc Natl Acad Sci USA,1995
3. An overview of the immune system;Parkin;Lancet,2001
4. The mechanisms of T cell selection in the thymus;Takaba;Trends Immunol,2017
5. Mechanisms of tolerance to self;Miller;Curr Opin Immunol,1996
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for Cancer;2024-06-01
2. Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression;Proceedings of the National Academy of Sciences;2023-11-27
3. The Value of Microbes in Cancer Neoantigen Immunotherapy;Pharmaceutics;2023-08-14
4. CrossDome: an interactive R package to predict cross-reactivity risk using immunopeptidomics databases;Frontiers in Immunology;2023-06-12
5. Solving the puzzle of what makes immunotherapies work;Trends in Cancer;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3